WXSH-0011

N/A

Report date: 2025/01/26 17:14:24
NME

Base Information

Drug NameWXSH-0011
Drug Alias Namedual FGFR/c-Met inhibitor (WuXi AppTec)WXSH-0011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors antagonistsHepatocyte growth factor receptor inhibitors
TargetsFibroblast growth factor receptorsHepatocyte growth factor receptor
Therapy Area/IndicationsStomach NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuxi Apptec Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuxi Apptec Co Ltd
Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A